Miromatrix Medical Inc

XNAS: MIRO

Watchlist

Portfolio

Share
-

Market Cap

-

PE TTM

-

PEG TTM

-

Price to Book

-

Beta 1Year



Insider Trading disclosures for Miromatrix Medical Inc

The latest disclosure was made by John L. Erb in Miromatrix Medical Inc where a trade of 54,201 Common Stock done was reported to US exchanges on June 1, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
John L. Erb Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 54,201 110,461 - 0 Common Stock
Peter Maag Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 54,201 120,460 - 0 Common Stock
Lisa Wipperman Heine Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 54,201 134,356 - 0 Common Stock
William P. Burke Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 54,201 134,356 - 0 Common Stock
Paul R. Buckman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 54,201 106,794 - 0 Common Stock
Paul R. Buckman Director Purchase of securities on an exchange or from another person at price $ 1.60 per share. 10 Mar 2023 31,250 52,593 - 1.6 50,000 Common Stock
John Barry VICE PRESIDENT OF R&D Purchase of securities on an exchange or from another person at price $ 1.60 per share. 10 Mar 2023 6,250 35,485 - 1.6 10,000 Common Stock
James M. Douglas CHIEF FINANCIAL OFFICER Purchase of securities on an exchange or from another person at price $ 1.60 per share. 10 Mar 2023 31,250 51,250 - 1.6 50,000 Common Stock
Jeffrey Ross Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 1.60 per share. 10 Mar 2023 31,250 396,276 - 1.6 50,000 Common Stock
Lisa Wipperman Heine Director Purchase of securities on an exchange or from another person at price $ 1.60 per share. 10 Mar 2023 31,250 80,155 - 1.6 50,000 Common Stock
William P. Burke Director Purchase of securities on an exchange or from another person at price $ 1.60 per share. 10 Mar 2023 31,250 80,155 - 1.6 50,000 Common Stock
Peter Maag Director Purchase of securities on an exchange or from another person at price $ 1.60 per share. 10 Mar 2023 31,250 66,259 - 1.6 50,000 Common Stock
John L. Erb Director Purchase of securities on an exchange or from another person at price $ 1.60 per share. 10 Mar 2023 31,250 56,260 - 1.6 50,000 Common Stock
John Barry VICE PRESIDENT OF R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2023 10,000 29,235 - 0 Common Stock
John Barry VICE PRESIDENT OF R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2023 20,000 20,000 - - Employee Stock Option (right to buy)
Jeffrey Ross Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2023 100,000 100,000 - - Employee Stock Option (right to buy)
Jeffrey Ross Director, CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.26 per share. 13 Jan 2023 4,487 365,026 - 3.3 14,628 Common Stock
Jeffrey Ross Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2023 50,000 369,513 - 0 Common Stock
James M. Douglas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2023 40,000 40,000 - - Employee Stock Option (right to buy)
James M. Douglas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2023 20,000 20,000 - 0 Common Stock
Jeffrey Ross Director, CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.05 per share. 06 Dec 2022 11,575 319,513 - 4.1 46,879 Common Stock
Jeffrey Ross Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.25 per share. 06 Dec 2022 37,500 331,088 - 1.3 46,875 Common Stock
Jeffrey Ross Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Dec 2022 37,500 0 - - Employee Stock Option (right to buy)
John Barry VICE PRESIDENT OF R&D Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.38 per share. 01 Oct 2022 765 19,235 - 4.4 3,351 Common Stock
Lisa Wipperman Heine Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2022 12,788 48,905 - 0 Common Stock
Paul R. Buckman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2022 12,788 21,343 - 0 Common Stock
William P. Burke Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2022 12,788 48,905 - 0 Common Stock
Peter Maag Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2022 12,788 35,009 - 0 Common Stock
John L. Erb Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2022 12,788 25,010 - 0 Common Stock
Jeffrey Ross Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2022 35,438 0 - - Employee Stock Option (right to buy)
Jeffrey Ross Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.25 per share. 15 Mar 2022 35,438 293,588 - 1.3 44,298 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters